Infliximab

High Quality Content by WIKIPEDIA articles Infliximab (INN; trade name Remicade) is a monoclonal antibody against tumour necrosis factor alpha (TNFα). It is used to treat autoimmune diseases. Remicade is marketed by Janssen Biotech, Inc. (formerly Centocor Biotech, Inc.) in the USA, Mitsubishi Tanabe Pharma in Japan, Xian Janssen in China, and Schering-Plough (now part of Merck Co) elsewhere.

• Format: Paperback
• Language: English
• ISBN: 551223465X
• ISBN13: 9785512234655
• Release Date: January 1
• Publisher: Book on Demand Ltd.
• Length: 88 Pages
• Weight: 0.48 lbs.
• Dimensions: 0.2" x 8.3" x 11.0"